1. Home
  2. MDXG vs ALX Comparison

MDXG vs ALX Comparison

Compare MDXG & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • ALX
  • Stock Information
  • Founded
  • MDXG 2006
  • ALX 1928
  • Country
  • MDXG United States
  • ALX United States
  • Employees
  • MDXG N/A
  • ALX N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • ALX Real Estate Investment Trusts
  • Sector
  • MDXG Health Care
  • ALX Real Estate
  • Exchange
  • MDXG Nasdaq
  • ALX Nasdaq
  • Market Cap
  • MDXG 1.3B
  • ALX 1.1B
  • IPO Year
  • MDXG N/A
  • ALX N/A
  • Fundamental
  • Price
  • MDXG $8.79
  • ALX $192.37
  • Analyst Decision
  • MDXG Strong Buy
  • ALX Sell
  • Analyst Count
  • MDXG 5
  • ALX 1
  • Target Price
  • MDXG $12.00
  • ALX $125.00
  • AVG Volume (30 Days)
  • MDXG 596.0K
  • ALX 11.9K
  • Earning Date
  • MDXG 02-26-2025
  • ALX 02-10-2025
  • Dividend Yield
  • MDXG N/A
  • ALX 9.37%
  • EPS Growth
  • MDXG N/A
  • ALX N/A
  • EPS
  • MDXG 0.52
  • ALX 9.25
  • Revenue
  • MDXG $342,804,000.00
  • ALX $233,399,000.00
  • Revenue This Year
  • MDXG $9.56
  • ALX N/A
  • Revenue Next Year
  • MDXG $9.19
  • ALX N/A
  • P/E Ratio
  • MDXG $17.47
  • ALX $20.78
  • Revenue Growth
  • MDXG 10.93
  • ALX 8.52
  • 52 Week Low
  • MDXG $5.47
  • ALX $184.76
  • 52 Week High
  • MDXG $10.14
  • ALX $251.63
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 44.77
  • ALX 41.59
  • Support Level
  • MDXG $8.50
  • ALX $190.48
  • Resistance Level
  • MDXG $9.36
  • ALX $196.39
  • Average True Range (ATR)
  • MDXG 0.27
  • ALX 4.13
  • MACD
  • MDXG -0.02
  • ALX 1.13
  • Stochastic Oscillator
  • MDXG 33.72
  • ALX 47.50

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About ALX Alexander's Inc.

Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.

Share on Social Networks: